Form 4: Glen A. Taylor Reports Changes in Beneficial Ownership of Envoy Medical, Inc. Stock
SEC Form 4
Glen A. Taylor, a director and 10% owner of Envoy Medical, Inc., filed a Form 4 detailing changes in beneficial ownership, including the acquisition of warrants.
Summary
- Glen A. Taylor, a director and 10% owner of Envoy Medical, Inc. (COCH), reported changes in beneficial ownership.
- The report includes direct ownership of 2,953,607 shares of Class A Common Stock.
- Taylor also indirectly owns 2,526,058 shares through Taylor Sports Group and 4,810,384 shares through GAT Funding, LLC.
- A warrant to purchase 750,000 shares of Class A Common Stock at $1.35 was acquired on March 11, 2025, exercisable immediately and expiring on March 11, 2028.
- This warrant was issued in connection with a promissory note issuance and initial funding, as detailed in the company's 8-K filing on March 12, 2025.
- Taylor also indirectly owns multiple other warrants through GAT Funding, LLC with varying exercise prices and expiration dates.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a regulatory filing detailing transactions. The acquisition of warrants could be seen as a positive signal, but it's not definitive.
Positives
- The acquisition of warrants by a significant shareholder could be interpreted as a sign of confidence in the company's future prospects.
Industry Context
Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the trading activities of insiders.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider transactions.
- The acquisition of warrants by a significant shareholder could influence investor sentiment.
Key Dates
| Date | Description |
|---|---|
| 02/27/2024 | Date of warrant exercisability (Warrant with exercise price of $1.24) |
| 05/23/2024 | Date of warrant exercisability (Warrant with exercise price of $3.04) |
| 07/22/2024 | Date of warrant exercisability (Warrant with exercise price of $2.25) |
| 08/27/2024 | Date of warrant exercisability (Warrant with exercise price of $2.97) |
| 12/11/2024 | Date of warrant exercisability (Warrant with exercise price of $2.20) |
| 03/06/2025 | Effective date of promissory note issuance |
| 03/11/2025 | Date of transaction and closing of initial funding; Acquisition of warrant to purchase 750,000 shares at $1.35 |
| 03/12/2025 | Envoy Medical's 8-K filing with the SEC |
| 03/13/2025 | Date of Form 4 filing |
| 02/27/2026 | Expiration date of multiple warrants held by GAT Funding, LLC |
| 08/27/2026 | Expiration date of multiple warrants held by GAT Funding, LLC |
| 03/11/2028 | Expiration date of warrant to purchase 750,000 shares at $1.35 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.